Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and ...

Further information The panel agreed the technology is not appropriate to be selected for guidance development as there is insufficient evidence. For further information on how we select topics for ...